Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

被引：0
|
作者：
Brian R. Ott
Lesley M. Blake
Ethel Kagan
Malca Resnick
机构：
[1] Rhode Island Hospital – APC 6,The Alzheimer’s Disease & Memory Disorders Center
[2] Northwestern University,Department of Psychiatry
[3] Harborside Financial Center,Forest Laboratories, Inc.
来源：
Journal of Neurology | 2007年 / 254卷
关键词：
Alzheimer’s disease; memantine; open label; randomized controlled trial; ADAS-cog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 358
页数：7
相关论文
共 50 条
  • [1] Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer's disease
    Ott, Brian R.
    Blake, Lesley M.
    Kagan, Ethel
    Resnick, Malca
    JOURNAL OF NEUROLOGY, 2007, 254 (03) : 351 - 358
  • [2] Long-term safety and tolerability of memantine: an open-label extension study in patients with mild to moderate Alzheimer's disease
    Bakchine, S.
    Rainer, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S529 - S529
  • [3] Safety and Tolerability of the Rivastigmine Patch Results of a 28-week Open-label Extension
    Grossberg, George
    Sadotvsky, Carl
    Foerstl, Haas
    Froelich, Lutz
    Nagel, Jennifer
    Tekin, Sibel
    Zechner, Stefanie
    Ros, Jacqueline
    Orgogozo, Jean-Marc
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2009, 23 (02): : 158 - 164
  • [4] Safety and Tolerability of Extended-Release Memantine in Patients with Moderate to Severe Alzheimer's Disease: An Open-Label Extension Study
    Alva, Gustavo
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Gutierrez Robledo, Luis Miguel
    Gloger, Sergio
    Xie, Lei
    Daniel Jia, Xinwei
    Perhach, James L.
    Graham, Stephen M.
    ANNALS OF NEUROLOGY, 2010, 68 (04) : S48 - S48
  • [5] Safety and Tolerability of Extended-Release Memantine (Once Daily, 28 mg) in Patients with Moderate to Severe Alzheimer's Disease: An Open-Label Extension Study
    Alva, Gustavo
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Guttierez Robledo, Luis Miguel
    Gloger, Sergio
    Xie, Lei
    Jia, Xinwei Daniel
    Perhach, James L.
    Graham, Stephen M.
    NEUROLOGY, 2010, 74 (09) : A394 - A395
  • [6] An Open-Label Extension Study Evaluating the Safety and Tolerability of Extended-Release Memantine (Once Daily, 28 Mg) in Patients with Moderate to Severe Alzheimer's Disease
    Alva, Gustavo
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Gutierrez Robledo, Luis Miguel
    Gloger, Sergio
    Xie, Lei
    Jia, Xinwei D.
    Perhach, James L.
    Graham, Stephen M.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S72 - S73
  • [7] A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease
    Reisberg, B
    Doody, R
    Stöffler, A
    Schmitt, F
    Ferris, S
    Möbius, HJ
    ARCHIVES OF NEUROLOGY, 2006, 63 (01) : 49 - 54
  • [8] Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
    Rikkert, Marcel G. M. Olde
    Verhey, Frans R.
    Blesa, Rafael
    von Arnim, Christine A. F.
    Bongers, Anke
    Harrison, John
    Sijben, John
    Scarpini, Elio
    Vandewoude, Maurits F. J.
    Vellas, Bruno
    Witkamp, Renger
    Kamphuis, Patrick J. G. H.
    Scheltens, Philip
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 471 - 480
  • [9] A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
    Ruether, E
    Husmann, R
    Kinzler, E
    Diabl, E
    Klingler, D
    Spatt, J
    Ritter, R
    Schmidt, R
    Taneri, Z
    Winterer, W
    Koper, D
    Kasper, S
    Rainer, M
    Moessler, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 253 - 263
  • [10] Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study
    Nakamura, Yu
    Omori, Takumi
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 685 - 693
12345